BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15989888)

  • 1. [Cost and management of asthma exacerbations in Spanish hospitals (COAX study in hospital services)].
    Borderías Clau L; Zabaleta Murguionda M; Riesco Miranda JA; Pellicer Ciscar C; Hernández Hernández JR; Carrillo Díaz T; Lumbreras García G
    Arch Bronconeumol; 2005 Jun; 41(6):313-21. PubMed ID: 15989888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adult asthma exacerbations in questions].
    Montani D; Cavailles A; Bertoletti L; Botelho A; Cortot A; Taillé C; Marchand-Adam S; Pinot D; Chouaid C; Crestani B; Garcia G; Humbert M; L'huillier JP; Magnan A; Tillie-Leblond I; Chanez P
    Rev Mal Respir; 2010 Dec; 27(10):1175-94. PubMed ID: 21163396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of severe asthma exacerbations in Spain: multicentre observational study.
    Quirce S; Melero C; Huerta A; Uría E; Cuesta M
    J Asthma; 2021 Feb; 58(2):207-212. PubMed ID: 31621441
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic impact of severe asthma in Spain: multicentre observational longitudinal study.
    Melero Moreno C; Quirce S; Huerta A; Uría E; Cuesta M
    J Asthma; 2019 Aug; 56(8):861-871. PubMed ID: 30003827
    [No Abstract]   [Full Text] [Related]  

  • 5. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.
    Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M
    J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute severe asthma: new approaches to assessment and treatment.
    Papiris SA; Manali ED; Kolilekas L; Triantafillidou C; Tsangaris I
    Drugs; 2009; 69(17):2363-91. PubMed ID: 19911854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
    Oostenbrink JB; Rutten-van Mölken MP; Monz BU; FitzGerald JM
    Value Health; 2005; 8(1):32-46. PubMed ID: 15841892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of bronchial asthma.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for acute asthma in the Emergency Department: practical aspects.
    Urso DL
    Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):209-14. PubMed ID: 20391960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of bronchial asthma exacerbation].
    Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():30-2. PubMed ID: 15524010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled steroid therapy and hospitalization for bronchial asthma: trend in Tokushima University Hospital.
    Yanagawa H; Shiraga M; Nakamura Y; Azuma M; Yoneda K; Ogawa H; Kitamuro C; Maeda K; Miki M; Matsumori Y; Sugita A; Hashimoto S; Hara C; Tani K; Sone S
    J Med Invest; 2003 Feb; 50(1-2):72-7. PubMed ID: 12630571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood asthma: treatment update.
    Courtney AU; McCarter DF; Pollart SM
    Am Fam Physician; 2005 May; 71(10):1959-68. PubMed ID: 15926412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
    Suruki RY; Daugherty JB; Boudiaf N; Albers FC
    BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications and Recent Patents for Status Asthmaticus in Children.
    Hon KLE; Leung AKC
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):12-21. PubMed ID: 28137226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.